Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
271.00    4.00 (1.50%)
Bid:
260.00
Ask:
266.00
Spread: 6.00 (2.308%)
Market Cap: £242.70m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

AGM Statement and Q1 Trading Update

1 Nov 2018 07:00

RNS Number : 9329F
Wilmington PLC
01 November 2018
 

1 November 2018 

 

Wilmington plc

('Wilmington', 'the Group' or 'the Company')

AGM Statement and Q1 Trading Update

 

Wilmington plc, the provider of information, education and networking services in Risk & Compliance, Healthcare and Professional knowledge areas, today announces a trading update for the three month period to 30 September 2018. This statement is being made ahead of its Annual General Meeting that is taking place later today.

 

Trading Update

 

In what is traditionally the quietest trading period for the Group, revenue performance in the first quarter has been reasonable, with a mix of performances across the different divisions. Overall revenue reduced 1% on an organic basis (i.e. at constant currencies and after adjusting for acquisitions and disposals) compared to the same period last year. This compares to the 3% organic revenue decline experienced across the prior year.

 

On a divisional basis, revenue in the Risk & Compliance division was up 7% organically, with good momentum in the main Compliance business, partly as a result of favourable timing issues that accelerated revenue from Q2 into the first three months this year. In the Healthcare division revenue declined 7% on an organic basis reflecting the reduction in deferred revenue noted in September's full year results announcement, as well as the continued impact of the decision to reduce US networking events to focus on improving profitability. Importantly from the perspective of future revenue progression in Healthcare, new business sales in the first quarter in the UK Healthcare business were up over 2% year on year and early indications for Q2 are that sales are expected to be further up compared to weak comparatives in the prior year. Revenue in the Professional businesses was flat year on year, excluding the impact of Ark, the legal services business that was closed in the first half of last year. 

 

Profit in the period, as anticipated, was down year on year due to the previously disclosed cost increases and investments made last year. This position was exacerbated slightly by a weaker than expected product mix in Q1 although this is expected to be a timing issue that will reverse over the course of the full year.

 

Net debt at 30 September 2018 was £44.4m (30 June 2018: £39.6m; 30 September 2017: £42.4m). The outflow since the start of the year is a function of usual seasonal outflows, and the final earn-out payment for SWAT which was acquired in July 2016.

 

Outlook

 

There is no change in anticipated trading outlook since the full year 2018 results announcement on 12 September 2018. The overall outcome from the divisional revenue and sales performance in the first quarter gives some early encouragement that momentum across the Group is starting to shift as required to achieve full year revenue and profit expectations. Whilst uncertainties remain within the macro economic environment, the changes in regulations that will come into force in the UK as a result of Brexit are likely to lead to new business opportunities in the second half of the year which will help to underpin our growth plans.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

For further information, please contact:

Wilmington plc

Pedro Ros, Chief Executive Officer

Richard Amos, Chief Financial Officer

 

FTI Consulting

Charles Palmer / Dwight Burden / Leah Dudley

020 7422 6800

 

 

 

020 3727 1000

 

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Healthcare and Professional areas. Wilmington employs close to 1,000 people and has customers in 120 countries. Wilmington plc is a premium listed company on the main market of the London Stock Exchange.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKEFDLLPFFF
Date   Source Headline
14th Aug 20201:38 pmRNSHolding(s) in Company
15th Jul 20202:08 pmRNSHolding(s) in Company
3rd Jul 20204:36 pmRNSPrice Monitoring Extension
2nd Jul 20206:30 pmRNSHolding(s) in Company
2nd Jul 20206:28 pmRNSHolding(s) in Company
2nd Jul 20206:23 pmRNSHolding(s) in Company
25th Jun 20207:00 amRNSPre-close Trading Update and Banking Arrangements
28th May 202010:18 amRNSHolding(s) in Company
21st May 20204:49 pmRNSHolding(s) in Company
20th May 20204:40 pmRNSSecond Price Monitoring Extn
20th May 20204:35 pmRNSPrice Monitoring Extension
13th May 20201:47 pmRNSHolding(s) in Company
2nd Apr 20207:00 amRNSEmployee Share Ownership Trust Purchase
27th Mar 202011:14 amRNSDirector/PDMR Shareholding
26th Mar 20204:18 pmRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSUpdate on COVID-19 Coronavirus Impact and Dividend
9th Mar 202010:02 amRNSEmployee Share Ownership Trust Purchase
9th Mar 20207:00 amRNSUpdate on COVID-19 Coronavirus
3rd Mar 20208:51 amRNSTotal Voting Rights
24th Feb 20204:41 pmRNSSecond Price Monitoring Extn
24th Feb 20204:36 pmRNSPrice Monitoring Extension
20th Feb 20207:00 amRNSDirectorate Change
20th Feb 20207:00 amRNSDirectorate Change
20th Feb 20207:00 amRNSHalf-year Report
20th Feb 20207:00 amRNSHalf-year Report
13th Feb 20202:22 pmRNSEmployee Share Ownership Trust Purchase
9th Jan 20209:20 amRNSEmployee Share Ownership Trust Purchase
2nd Jan 20209:02 amRNSTotal Voting Rights
19th Dec 201910:35 amRNSEmployee Share Ownership Trust Purchase
16th Dec 20193:19 pmRNSHolding(s) in Company
6th Dec 20193:16 pmRNSHolding(s) in Company
3rd Dec 20192:40 pmRNSEmployee Share Ownership Trust Purchase
2nd Dec 201910:44 amRNSTotal Voting Rights
2nd Dec 20199:07 amRNSEmployee Share Ownership Trust Purchase
25th Nov 201910:49 amRNSHolding(s) in Company
5th Nov 201912:57 pmRNSResult of AGM
5th Nov 20197:00 amRNSAGM Statement and Q1 Trading Update
1st Nov 20197:00 amRNSTotal Voting Rights
31st Oct 20194:35 pmRNSPrice Monitoring Extension
3rd Oct 20193:48 pmRNSDirector/PDMR Shareholding
1st Oct 20193:06 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSVoting Rights and Capital
20th Sep 20193:05 pmRNSDirector/PDMR Shareholding
19th Sep 20191:37 pmRNSREPLACEMENT: Share Awards
19th Sep 201911:59 amRNSShare Awards
19th Sep 20197:00 amRNSFinancial results for the year ended 30 June 2019
2nd Sep 201910:51 amRNSVoting Rights and Capital
22nd Aug 20193:03 pmRNSHolding(s) in Company
1st Aug 20197:00 amRNSTotal Voting Rights
9th Jul 20194:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.